Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mouwasat Medical Services Co (SAU:4002) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Mouwasat Medical Services Co Forward PE Ratio Related Terms
Mouwasat Medical Services Co Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mouwasat Medical Services Co Forward PE Ratio Chart
Mouwasat Medical Services Co Annual Data
Trend
2022-12
2024-12
2025-12
Forward PE Ratio
25.97
20.08
16.09
Mouwasat Medical Services Co Quarterly Data
2022-12
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
25.97
20.08
19.63
20.37
17.61
16.09
16.80
SAU:4002 vs HCA, THC, DVA: Forward PE Ratio Comparison
For the Medical Care Facilities subindustry, Mouwasat Medical Services Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mouwasat Medical Services Co Forward PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mouwasat Medical Services Co's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Mouwasat Medical Services Co's Forward PE Ratio falls into.
Mouwasat Medical Services Co Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Mouwasat Medical Services Co (SAU:4002) has a Forward PE Ratio of 14.98 as of Aug. 19, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Mouwasat Medical Services Co and its competitors. According to the industry distribution chart, Mouwasat Medical Services Co ranks #108 out of 316 companies in the Healthcare Providers & Services industry, placing it in the top 34.2%.
Is Mouwasat Medical Services Co's Forward PE Ratio too high?
Mouwasat Medical Services Co's current Forward PE Ratio is 14.98. The Healthcare Providers & Services industry median Forward PE Ratio is 18.87. Mouwasat Medical Services Co's value of 14.98 is 20.6% below this industry median. Based on the distribution chart, Mouwasat Medical Services Co ranks #108 out of 316 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Mouwasat Medical Services Co has a GF Score™ of 100/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mouwasat Medical Services Co's Forward PE Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Mouwasat Medical Services Co ranks #108 out of 316 companies for Forward PE Ratio. This puts Mouwasat Medical Services Co in the upper half of its industry. The industry median Forward PE Ratio is 18.87. Mouwasat Medical Services Co's value of 14.98 is 20.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 18.87, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mouwasat Medical Services Co's current Forward PE Ratio of 14.98 is 20.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Mouwasat Medical Services Co and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 18.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mouwasat Medical Services Co's current Forward PE Ratio is 14.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mouwasat Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Mouwasat Medical Services Co (SAU:4002) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼110.50, compared to a current price of ﷼63.90 — trading 42.2% below its estimated fair value. The current Forward PE Ratio is 14.98 and 20.6% below the Healthcare Providers & Services industry median of 18.87. Mouwasat Medical Services Co's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Mouwasat Medical Services Co (SAU:4002), the current Forward PE Ratio is 14.98 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mouwasat Medical Services Co (SAU:4002) Overvalued in 2026?
Based on GuruFocus' analysis, Mouwasat Medical Services Co stock appears to be undervalued.
The current stock price of ﷼63.90 is trading 42.2% below its estimated GF Value™ of ﷼110.50.
GuruFocus considers Mouwasat Medical Services Co to be Significantly Undervalued.
Key valuation signals for SAU:4002:
Forward PE Ratio: 14.98
GF Value™: ﷼110.50 vs. price of ﷼63.90 (42.2% below fair value)
Industry Position: 20.6% below the Healthcare Providers & Services median (#108 of 316)
No single metric tells the full story. See the SAU:4002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue. The Medical Services segment includes Inpatient and outpatient services. The company provides specialized centers: Eye Center, Robotic Surgeries Center, Diabetes Center, Fertility Unit, Cardiology Center, Stroke Unit, Long Term Care Center, Obesity Center, and others.
100GF Score
Get the complete analysis for SAU:4002
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4002 has been successfully added to your 
